[Corrigendum] miR-9 regulates the multidrug resistance of chronic myelogenous leukemia by targeting ABCB1

[更正] miR-9 通过靶向 ABCB1 调控慢性粒细胞白血病的多药耐药性

阅读:1

Abstract

Following the publication of this article, the authors have subsequently realized that Fig. 2D (lower middle panel, K562‑control group treated with paclitaxel) contained the same data as the left lower panel (K562 group). The authors have examined their original data, and realize that the same data was inadvertently included in this Figure twice. Consequently, the corrected version of Fig. 2, featuring the correct data for the lower middle panel (K562‑control group treated with paclitaxel), is shown opposite. The overall conclusions of this study were not affected by this error. The authors regret that this error was introduced into the printed version of the paper, and apologize to the readership for any inconvenience caused. [the original article was published in Oncology Reports 37: 2193‑2200, 2017; DOI: 10.3892/or.2017.5464.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。